Company Profile
Virax Biolabs Group Limited is a biotechnology company focused on immune-response detection and T cell immune profiling. The Company is developing in vitro diagnostic technologies for viral and immune-mediated diseases, with an initial strategic focus on post-acute infection syndromes, including Long COVID, and related areas of chronic immune dysfunction. Its principal programs are ViraxImmune™, an in-development T cell-based immune-profiling and diagnostic platform, and ImmuneSelect, a research-use-only portfolio of peptide pools, ELISpot plates and related immune reagents.
Latest Presentation
Industry Classifications
Sector:
Biotechnology
Industry:
In Vitro Diagnostics
NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC:
In Vitro And In Vivo Diagnostic Substances (2835)
Contact Information
Investor Relations
RedChip Companies, Inc.
Dave Gentry, CEO
M: 1-407-644-4256
VRAX@redchip.com
Company Contact
Virax Biolabs Group Limited
BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire ML1 5UH
United Kingdom
T: +44 20 7788 7414
info@viraxbiolabs.com